FROM Alia Malek
Mixed messages from America's new hard line on Syria Last week, President Trump stunned the world by striking Syria with 59 Tomahawk missiles in retaliation for Bashar al-Assad's use of chemical weapons against his own people. Since then, American diplomats have made contradictory statements in the aftermath of the attack. Was it a "one-off" or is regime change the goal? And why has President Trump retaliated against Syria's use of chemical weapons — but not conventional weapons, which are just as deadly? America's G-7 allies are meeting in Italy to find a consensus for dealing with Syria -- and with Russia — the next stop for America's Secretary of State. Is it too soon for the "political solution" all sides claim to prefer, or will force be used in attempting to remove the Assad regime from power?
Will the Senate write a healthcare bill in secret? While Democrats and Republicans argue White House relations with Russia, another question is being decided behind closed doors: who gets help buying health insurance and who doesn't? We hear how the pros and cons are being shrouded in secrecy.
Who's to blame for the opioid crisis? Some of the lawyers who took on Big Tobacco are now going after Big Pharma. It’s all about the deadly epidemic of opioid use. Are the drug companies to blame? What about the users? Later, on today’s Talking Point: making sense of Britain’s upset election.
Is the threat from Russia missing from the Russia meddling probe? There's much being made about the Trump administration's possible ties with Russia. But the bottom line is Russia's effort to influence American democracy. Do the President and his aides care enough to take action before voters go back to the polls?